Category:
Active Pharmaceutical Ingredients
CAS NO:
1374640-70-6
Standard:
In-house Standards,
Oncology Lung Cancer
Rociletinib is an investigational third-generation EGFR tyrosine kinase inhibitor developed for non-small cell lung cancer. Its core synthesis involves complex heterocyclic coupling. The molecular formula is C24H25FN6O2 with CAS number 1229806-77-6.
Strictly restricted to clinical trial settings due to halted Phase III status. Requires storage in cool, dry conditions away from light. Handling mandates PPE to prevent inhalation or skin contact of active pharmaceutical ingredients.